Ferring Pharmaceuticals
| Organization type | biotech |
|---|
Ferring Pharmaceuticals is a research-driven specialty biopharmaceutical group headquartered in Saint-Prex, Switzerland. Its 2015 press release announced early-stage development of a bacteriophage therapy for inflammatory bowel disease with Intralytix, and Capsid & Tail has featured Ferring speakers at Phage Futures in 2021 and 2022.
| Website | Website |
|---|